Ritter Pharmaceuticals, Inc. (RTTR)
(Delayed Data from NSDQ)
$0.75 USD
-0.03 (-3.83%)
Updated May 3, 2019 04:13 PM ET
After-Market: $0.75 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Qualigen Therapeutics, Inc. [RTTR]
Reports for Purchase
Showing records 1 - 20 ( 56 total )
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
We are dropping coverage of RTTR to reallocate our research resources.
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
1Q19 Recap - Data Coming Early 4Q19 (or Possibly 3Q)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
4Q18 Recap - Liberatus Fully Enrolled, Data by 4Q19
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
Discontinuing coverage due to resource reallocation.
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Qualigen Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.